02877 SHINEWAY PHARM
Trading Add to PorfolioKey Financial Ratio (Fiscal Year: 12/2024) | |||
Current | 3.51X | Oper Margin | 30.5% |
---|---|---|---|
LT Debt/Equity | 0.1% | Net Margin | 22.2% |
Total Debt/Equity | 4.6% | Return on Equity | 11.3% |
Price/Book | 0.90X | Return on Assets | 8.4% |
(HKD 8.680) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
Net Profit (MHKD) | 893.40 | 1,068.59 | 810.37 | 680.87 | 350.15 |
---|---|---|---|---|---|
Net Profit Growth (%) | -16.4 | +31.9 | +19.0 | +94.5 | -37.8 |
Earnings Per Share (HKD) | 1.183 | 1.415 | 1.073 | 0.902 | 0.463 |
Earnings Per Share Growth (%) | -16.4 | +31.9 | +19.0 | +94.9 | -35.8 |
Dividend Per Share (HKD) | 0.966 | 0.471 | 0.383 | 0.470 | 0.380 |
P/E* (X) | 7.34 | 6.14 | 8.09 | 9.63 | 18.76 |
Yield (%) | 11.13 | 5.43 | 4.41 | 5.41 | 4.38 |
Dividend Share (%) | 81.68 | 33.30 | 35.70 | 52.09 | 82.08 |
Book NAV (HKD) | 9.602 | 9.376 | 8.653 | 8.728 | 8.315 |
Auditors' Opinion | Unqualified | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-09-07 21:40:22
Latest Result
(RMBMn) | 2025-06 | 2024-06 | Chg* (%) | 2023-06 |
Cover Period (mths) | 6 | 6 | NA | 6 |
---|---|---|---|---|
Turnover | 1,653 | 2,087 | -20.8 | 2,399 |
Operating Result | 774.678 | 862.083 | -10.1 | 671.288 |
Profit Before Taxation | 774.678 | 862.083 | -10.1 | 671.288 |
Taxation | 160.015 | 235.604 | -32.1 | 179.823 |
Profit /( Loss) After Taxation | 614.663 | 626.479 | -1.9 | 491.465 |
Net Profit | 614.663 | 626.479 | -1.9 | 491.465 |
Earnings Per Share () | 0.8916 | 0.8913 | +0.0 | 0.7021 |
Dividend Per Share () | 0.1205 | 0.1200 | +0.4 | 0.1180 |
Announcement Date | 2025-08-27 | 2024-08-29 | NA | 2023-08-30 |
* Annualised
Last Update Time: 2025-09-07 21:40:27